Skip to main content
Log in

A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit

  • Letter
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Colomb-Cotinat M, Lacoste J, Brun-Buisson C et al (2016) Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012. Antimicrob Resist Infect Control 5:56. https://doi.org/10.1186/s13756-016-0154-z

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Bassetti M, Poulakou G, Ruppe E et al (2017) Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. Intensive Care Med. https://doi.org/10.1007/s00134-017-4878-x

    Article  PubMed  Google Scholar 

  3. Guggenbichler J, Kofler J, Allerberger F (1985) The influence of third-generation cephalosporins on the aerobic intestinal flora. Infection 13:S137–S139

    Article  PubMed  Google Scholar 

  4. Grohs P, Kerneis S, Sabatier B et al (2014) Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime. J Antimicrob Chemother 69:786–789. https://doi.org/10.1093/jac/dkt403

    Article  PubMed  CAS  Google Scholar 

  5. McDonnell L, Armstrong D, Ashworth M et al (2017) National disparities in the relationship between antimicrobial resistance and antimicrobial consumption in Europe: an observational study in 29 countries. J Antimicrob Chemother 72:3199–3204. https://doi.org/10.1093/jac/dkx248

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

BKT, EV, JRZ, LT, and MH contributed substantially to the conception and design of the study. BKT, EV, CPo, LP, CPa, PM, CH, and PP performed the data acquisition. BKT, KAB, and MH analyzed the data. BKT, EV, JRZ, CPo, CPa, KAB, LT, and MH interpreted the data. BKT drafted the article. EV, JRZ, LT, and MH provided critical revision of the article. BKT, EV, KAB, JRZ, CPo, LPa, CP, PM, CH, PP, LT and MH provided final approval for the version submitted for publication.

Corresponding author

Correspondence to Boun Kim Tan.

Ethics declarations

Conflict of interest

All authors report no conflict of interest relevant to this study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 309 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, B.K., Vivier, E., Bouziad, K.A. et al. A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit. Intensive Care Med 44, 672–673 (2018). https://doi.org/10.1007/s00134-018-5079-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-018-5079-y

Navigation